Strata Critical Medical Past Earnings Performance
Past criteria checks 0/6
Strata Critical Medical's earnings have been declining at an average annual rate of -15.3%, while the Airlines industry saw earnings growing at 56.1% annually. Revenues have been growing at an average rate of 39.4% per year.
Key information
-15.26%
Earnings growth rate
12.95%
EPS growth rate
| Airlines Industry Growth | 0.092% |
| Revenue growth rate | 39.37% |
| Return on equity | -8.51% |
| Net Margin | -7.46% |
| Next Earnings Update | 10 Nov 2025 |
Recent past performance updates
Recent updates
Earnings Release: Here's Why Analysts Cut Their Blade Air Mobility, Inc. (NASDAQ:BLDE) Price Target To US$7.20
May 15
Blade Air Mobility, Inc. (NASDAQ:BLDE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
May 13
eVTOL And Urban Air Mobility Will Open New Routes
Transition to electric vertical aircraft (eVTOL) promises long-term growth by enabling new routes and attracting a wider customer base.Blade Air Mobility: Organ Transport Growth Now, eVTOL Growth Later
Feb 26Revenues Not Telling The Story For Blade Air Mobility, Inc. (NASDAQ:BLDE) After Shares Rise 27%
Nov 30Blade: Transition To Profitability Should Provide Support Going Forward
Nov 18Analysts Have Made A Financial Statement On Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Third-Quarter Report
Nov 15Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Business Is Trailing The Industry But Its Shares Aren't
Sep 16Blade: Margins Remain An Issue
Aug 15Here's Why We're Not At All Concerned With Blade Air Mobility's (NASDAQ:BLDE) Cash Burn Situation
Jun 19Blade Air Mobility: No Signs Of Competition Yet
May 16Analysts Are Updating Their Blade Air Mobility, Inc. (NASDAQ:BLDE) Estimates After Its First-Quarter Results
May 10Blade Air Mobility, Inc.'s (NASDAQ:BLDE) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Mar 20Blade Air Mobility, Inc. (NASDAQ:BLDE) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 15We're Not Very Worried About Blade Air Mobility's (NASDAQ:BLDE) Cash Burn Rate
Mar 07Blade Air Mobility, Inc.'s (NASDAQ:BLDE) Share Price Matching Investor Opinion
Jan 24Blade Air Mobility: Takeoff Towards Profitability
Jan 21We're Not Very Worried About Blade Air Mobility's (NASDAQ:BLDE) Cash Burn Rate
Jul 24Blade Air Mobility, Inc.'s (NASDAQ:BLDE) 26% Jump Shows Its Popularity With Investors
Jun 30Blade Air Mobility (NASDAQ:BLDE) Is In A Good Position To Deliver On Growth Plans
Apr 06Revenue & Expenses Breakdown
How Strata Critical Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 254 | -19 | 76 | 3 |
| 31 Mar 25 | 251 | -27 | 82 | 3 |
| 31 Dec 24 | 249 | -27 | 82 | 3 |
| 30 Sep 24 | 242 | -51 | 90 | 3 |
| 30 Jun 24 | 238 | -49 | 92 | 4 |
| 31 Mar 24 | 231 | -50 | 82 | 4 |
| 31 Dec 23 | 225 | -56 | 82 | 5 |
| 30 Sep 23 | 216 | -38 | 82 | 5 |
| 30 Jun 23 | 190 | -47 | 75 | 6 |
| 31 Mar 23 | 165 | -26 | 71 | 6 |
| 31 Dec 22 | 146 | -27 | 67 | 6 |
| 30 Sep 22 | 133 | -11 | 61 | 5 |
| 30 Jun 22 | 107 | -11 | 57 | 3 |
| 31 Mar 22 | 85 | -44 | 53 | 3 |
| 31 Dec 21 | 67 | -37 | 43 | 2 |
| 30 Sep 21 | 51 | -40 | 33 | 2 |
| 30 Jun 21 | 39 | -32 | 22 | 1 |
| 31 Mar 21 | 29 | -9 | 14 | 1 |
| 31 Dec 20 | 26 | -8 | 12 | 1 |
| 30 Sep 20 | 23 | -10 | 12 | 1 |
| 30 Sep 19 | 31 | -11 | 15 | 1 |
Quality Earnings: SRTA is currently unprofitable.
Growing Profit Margin: SRTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRTA is unprofitable, and losses have increased over the past 5 years at a rate of 15.3% per year.
Accelerating Growth: Unable to compare SRTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SRTA is unprofitable, making it difficult to compare its past year earnings growth to the Airlines industry (-0.5%).
Return on Equity
High ROE: SRTA has a negative Return on Equity (-8.51%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 17:03 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Strata Critical Medical, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Itay Michaeli | Citigroup Inc |
| Xin Yu | Deutsche Bank |
| Hillary Cacanando | Deutsche Bank |